Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
about
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyChronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.Mechanisms of lipotoxicity in the cardiovascular system.Remodeling of energy metabolism and absence of electrophysiological changes in the heart of obese hyperleptinemic mice. New insights into the pleiotropic role of leptin.Sphingolipids and lifespan regulation.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.Targeting ceramide metabolism in obesity.MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production.Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
P2860
Q26859582-EC4CD8E0-A9C4-4BB9-99B2-75FCD8A27F98Q27316398-645D4A15-33DE-4E91-8797-5A06A8C7A899Q35140908-BCB02469-A5FF-4B2E-BEAA-00E036C5AE6EQ36377252-ED55E059-D5D4-49C6-BADA-0D6C4F7F37C9Q37310128-ABFDE607-572F-4230-A19C-353E93A53994Q37586487-AC487102-6458-4B55-AFB2-0DB50B7C2173Q37688533-E0F71229-A5CE-4CF4-AD8F-1A773DE33D4AQ38129182-0E198727-7213-4A47-89B4-2188C75D4E81Q38778327-8C351D6A-0E5C-480F-B8BC-1F727C7C75D4Q38887432-0E314788-5A72-4532-AD80-F413BE533A24Q39038069-BF5E4B42-1AD2-40F2-BAAC-70098401EF47Q42395469-013559AA-0A1B-4073-A3E4-2D5E4E904E67Q42474437-5D1DBE7C-C65B-4900-A84F-A8C6D3328311Q42736812-3938CB4D-8B08-412A-A421-52BEB1B9E1BFQ47834016-B6DD4C1D-5F11-4C0A-A3ED-FCEA716C0270Q53573537-89AC1957-E2C9-4823-A486-DE3D1CD62767
P2860
Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of serine palmitoyl ...... et-induced insulin resistance.
@en
type
label
Inhibition of serine palmitoyl ...... et-induced insulin resistance.
@en
prefLabel
Inhibition of serine palmitoyl ...... et-induced insulin resistance.
@en
P2093
P2860
P1433
P1476
Inhibition of serine palmitoyl ...... iet-induced insulin resistance
@en
P2093
Clifford D L Folmes
Donna L Beker
Gary D Lopaschuk
Jagdip S Jaswal
John R Ussher
Liyan Zhang
Natasha Fillmore
Victoria H Lam
Virgilio J Cadete
P2860
P304
P356
10.1371/JOURNAL.PONE.0037703
P407
P50
P577
2012-05-22T00:00:00Z